Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Pricing Sign in

City Therapeutics, Inc. CTY

Full chart Compare
Set alert

Price alert · CTY

All alert types
19.31 USD +0.64 (+3.40%)

Nov 10, 2026, 10:05 AM EST

19.00 Day range 19.63
15.81 52-week range 23.88
YTD
-13.81%
1 year
-13.81%

Revenue & Expenses

Other Income → Expenses: $3.67MExpenses → Selling, General & Admin: $15.06MExpenses → Research & Development: $58.42MExpenses → Interest Expense: $2.26MGross Profit → Expenses: $13.56MRevenue → Gross Profit: $13.56MNet Loss → Expenses: $58.51MOther Income$3.67MGross Profit$13.56MNet Loss$58.51MExpenses$75.74MSelling, General & Admin$15.06MResearch & Development$58.42MInterest Expense$2.26MRevenue$13.56M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Income statement

Full income statement How to read it
CTY annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
13.56M2.78M
13.56M2.78M
-59.92M-29.09M
-58.51M-27.84M
-12.46-8.18

Balance sheet

Full balance sheet How to read it
CTY annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
115.30M128.43M
149.77M145.35M
89.91M30.26M
67.28M22.30M
-84.66M-29.43M

Cash flow

Full cash flow How to read it
CTY annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024
-41.61M-20.39M
-2.38M-3.38M
30.86M149.44M
-2.38M-3.38M
-13.13M125.67M